Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1119P is a pseudogene sequence derived from the U6 small nuclear RNA (snRNA) gene family. Pseudogenes like RNU6-1119P are nonfunctional copies or fragments of genes that share sequence homology to their functional counterparts but lack the ability to encode products due to disabling mutations or truncations[2][3][4][5]. U6 snRNA is an essential noncoding RNA component of the spliceosome involved in removing introns from pre-mRNA in eukaryotes[1]. Pseudogenes of U6 snRNA arise via retrotransposition or gene duplication events and are abundant in mammalian genomes, serving largely as evolutionary genomic relics without current biological or disease-related roles[3][5]. There is no evidence that RNU6-1119P is expressed or functional, and it is not a druggable or therapeutic target.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1119, pseudogene (RNU6-1119P).